Clinical Trial Update: Pulmonary Artery Remodelling With Bosentan [Phase 4]

View source ↗

Summary

Phase 4 study evaluating bosentan for pulmonary arterial hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Bosentan (Bosentan)

Snippet

Sponsor: Actelion | Conditions: Hypertension, Pulmonary | Phase 4 | Status: COMPLETED